Brief: Fusen Pharmaceutical And Taumedika Srl Enter Into Distribution Agreement
18/07/2022 14:39
July 18 (Reuters) - Fusen Pharmaceutical Co Ltd 1652.HK :
* CO AND TAUMEDIKA SRL, AN INDEPENDENT THIRD PARTY, ENTERED
INTO A
DISTRIBUTION AGREEMENT
* DEAL FOR EXCLUSIVE RIGHT TO MARKET, DISTRIBUTE AND SELL
KARISMA
SUPPLIED BY TAUMEDIKA SRL IN PEOPLE'S REPUBLIC OF CHINA
* EXPECTS TO BENEFIT FROM REVENUE GENERATED THROUGH
DISTRIBUTION
AGREEMENT
Further company coverage: 1652.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fusen Pharmaceutical
See all newsBrief: Fusen Pharmaceutical Logs HY Loss Attributable RMB13.6 Million
Brief: Fusen Pharmaceutical Says Doxazosin Mesylate Extended-Release Tablets Approved For Marketing In China
Brief: Fusen Pharmaceutical Says Peramivir Injection First Neuraminidase Inhibitor Approved In China For Intravenous Influenza Treatment
Brief: Fusen Pharmaceutical Says Investors To Contribute RMB300 Mln For 34% Stake Subscription Of Henan Fusen Pharmaceutical
Brief: Fusen Pharmaceutical Says Piracetam Injection Approved For Marketing By NMPA